Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Practicing Clinicians Exchange. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Practicing Clinicians Exchange or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Optimizing Immune Checkpoint Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer

12:51
 
Share
 

Manage episode 333078086 series 3264057
Content provided by Practicing Clinicians Exchange. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Practicing Clinicians Exchange or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode, Sandip Patel, MD shares his thoughts on optimizing immune checkpoint inhibitor (ICI) therapy in advanced non-small-cell lung cancer (NSCLC) and discusses best practices for individualizing therapy decisions and managing adverse events.

Topics include:

  • Currently approved ICIs
  • Role of biomarker and PD-L1 testing in advanced NSCLC
  • Strategies to individualize ICI treatment for patients with advanced NSCLC
  • Strategies for identifying and managing immune-related adverse events in patients treated with ICI

Presenter:
Sandip P. Patel, MD
Associate Professor
Department of Medicine
Division of Hematology/Oncology
University of California – San Diego
La Jolla, California

Link to full program:
https://bit.ly/39vuCHC

  continue reading

90 episodes

Artwork
iconShare
 
Manage episode 333078086 series 3264057
Content provided by Practicing Clinicians Exchange. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Practicing Clinicians Exchange or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

In this episode, Sandip Patel, MD shares his thoughts on optimizing immune checkpoint inhibitor (ICI) therapy in advanced non-small-cell lung cancer (NSCLC) and discusses best practices for individualizing therapy decisions and managing adverse events.

Topics include:

  • Currently approved ICIs
  • Role of biomarker and PD-L1 testing in advanced NSCLC
  • Strategies to individualize ICI treatment for patients with advanced NSCLC
  • Strategies for identifying and managing immune-related adverse events in patients treated with ICI

Presenter:
Sandip P. Patel, MD
Associate Professor
Department of Medicine
Division of Hematology/Oncology
University of California – San Diego
La Jolla, California

Link to full program:
https://bit.ly/39vuCHC

  continue reading

90 episodes

Minden epizód

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play